Libtayo (cemiplimab)

pCPA File Number: 22887

Negotiation Status:

Active Negotiation

Indication(s):

Basal cell carcinoma (BCC), locally advanced or metastatic, previously treated with a hedgehog pathway inhibitor

Sponsor/Manufacturer:

Regeneron

CDA-AMC Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2024-08-30

Negotiation Process Concluded:

Not Applicable